INDV - INDIVIOR PLC

QQQ $ 603.61 $ 0.00 (0 %)

DIA $ 464.81 $ 0.00 (0 %)

SPY $ 666.62 $ 0.00 (0 %)

TLT $ 90.99 $ 0.00 (0 %)

GLD $ 386.16 $ 0.00 (0 %)

Previous Close

$ 24.54

Open

$ 23.72

Bid

$ 24.54 x 311

Ask

$ 27.88 x 30

Day's Range

-- - --

52 Week Range

$ 7.62 - $ 25.10

Volume

2,306,300

Average Volume

Market Cap

3.06B

Beta (5Y Monthly)

$ 2.09

PE Ratio (TTM)

$ 29.16

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-31-2025	06-30-2025	10-Q
2	05-01-2025	03-31-2025	10-Q
3	03-03-2025	12-31-2024	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Craig-Hallum Maintains Buy on Indivior, Ra...
08/27/2025 17:54:11

Craig-Hallum analyst Chase Knickerbocker maintains Indivior (NASDAQ:INDV) with a Buy and raises the price target from $27 to...

this-palvella-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday

This Palvella Therapeutics Analyst Begins ...
08/06/2025 12:10:52

HC Wainwright & Co. Initiates Coverage On ...
08/06/2025 11:14:07

HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Indivior (NASDAQ:INDV) with a Buy rating and announces ...

roblox-carvana-ebay-ch-robinson-worldwide-huntington-ingalls-industries-and-other-big-stocks-moving-higher-on-thursday

Roblox, Carvana, eBay, C.H. Robinson World...
07/31/2025 15:00:57

Indivior Raises FY2025 Sales Guidance from...
07/31/2025 11:03:00

Indivior (NASDAQ:INDV) raises FY2025 sales outlook from $955.000 million-$1.025 billion to $1.030 billion-$1.080 billion vs $1....

Indivior Q2 Adj. EPS $0.51 Beats $0.25 Est...
07/31/2025 11:02:29

Indivior (NASDAQ:INDV) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.25 by 104...

Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

Indivior Publishes Results In Drug and Al...
07/23/2025 12:09:26

Jefferies Assumes Indivior at Buy, Announc...
07/22/2025 10:38:15

Jefferies analyst Dennis Ding assumes Indivior (NASDAQ:INDV) with a Buy rating and announces Price Target of $20.

Craig-Hallum Maintains Buy on Indivior, Ra...
06/30/2025 13:27:23

Craig-Hallum analyst Chase Knickerbocker maintains Indivior (NASDAQ:INDV) with a Buy and raises the price target from $15 to...

Indivior Will Be Added As A Member Of The ...
06/30/2025 11:12:59

Indivior Presents Data Showing 300 mg SUBL...
06/19/2025 13:02:39

A post-hoc analysis demonstrates that buprenorphine exposure with 300 mg SUBLOCADE® (buprenorphine extended-release) may improv...

Indivior To Delist From LSE, Citing US Rev...
06/02/2025 06:05:54

In further consideration of Indivior's listing structure, the Board now believes that the London Delisting will be benefici...

Addex Therapeutics Announces Milestone As ...
05/12/2025 06:23:58

Indivior Announces New Study Highlighting ...
05/01/2025 14:35:45

SUBLOCADE use during pregnancy showed no increased risk of birth defects, miscarriage, or maternal complications compared to ge...

Earnings Scheduled For April 24, 2025
04/24/2025 08:32:27

Indivior Reaffirms 2025 Guidance: Expects ...
04/24/2025 06:18:42

FY 2025 Guidance Unchanged The Company's guidance for FY 2025 under U.S. GAAP is unchanged. Guidance assumes no material ch...

Indivior Q1 Adj. EPS $0.41 Beats $0.24 Est...
04/24/2025 06:05:37

Indivior (NASDAQ:INDV) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.24 by 70....

A Look at Indivior's Upcoming Earnings Report
04/23/2025 21:02:39

Piper Sandler Maintains Overweight on Indi...
03/06/2025 14:14:02

Piper Sandler analyst David Amsellem maintains Indivior (NASDAQ:INDV) with a Overweight and lowers the price target from $16...